An update on the taxonomy and functional properties of the probiotic Enterococcus faecium SF68.

Benef Microbes

Human Effective Microbes Laboratory, Graduate School of Advanced Convergence, Handong Global University, Pohang, Gyeongbuk 37554, Republic of Korea.

Published: March 2024

Enterococcus faecium SF68 (SF68) is a well-known probiotic with a long history of safe use. Recent changes in the taxonomy of enterococci have shown that a novel species, Enterococcus lactis, is closely related with E. faecium and occurs together with other enterococci in a phylogenetically well-defined E. faecium species group. The close phylogenetic relationship between the species E. faecium and E. lactis prompted a closer investigation into the taxonomic status of E. faecium SF68. Using phylogenomics and ANI, the taxonomic analysis in this study showed that probiotic E. faecium SF68, when compared to other E. faecium and E. lactis type and reference strains, could be re-classified as belonging to the species E. lactis. Further investigations into the functional properties of SF68 showed that it is potentially capable of bacteriocin production, as a bacteriocin gene cluster encoding the leaderless bacteriocin EntK1 together with putative Lactococcus lactis bacteriocins LsbA, and LsbB-like putative immunity peptide (LmrB) were found located in an operon on plasmid pF9. However, bacteriocin expression was not studied. Competitive exclusion experiments in co-culture over 7 days at 37 °C showed that the probiotic SF68 could inhibit the growth of specific E. faecium and Listeria monocytogenes strains, while showing little or no inhibitory activity towards an entero-invasive Escherichia coli and a Salmonella Typhimurium strain, respectively. In cell culture experiments with colon carcinoma HT29 cells, the probiotic SF68 was also able to strain-specifically inhibit adhesion and/or invasion of enterococcal and L. monocytogenes strains, while such adhesion and invasion inhibition effects were less pronounced for E. coli and Salmonella strains. This study therefore provides novel data on the taxonomy and functional properties of SF68, which can be reclassified as Enterococcus lactis SF68, thereby enhancing the understanding of its probiotic nature.

Download full-text PDF

Source
http://dx.doi.org/10.1163/18762891-bja00005DOI Listing

Publication Analysis

Top Keywords

faecium sf68
16
functional properties
12
sf68
10
faecium
9
taxonomy functional
8
enterococcus faecium
8
enterococcus lactis
8
faecium lactis
8
properties sf68
8
probiotic sf68
8

Similar Publications

An update on the taxonomy and functional properties of the probiotic Enterococcus faecium SF68.

Benef Microbes

March 2024

Human Effective Microbes Laboratory, Graduate School of Advanced Convergence, Handong Global University, Pohang, Gyeongbuk 37554, Republic of Korea.

Enterococcus faecium SF68 (SF68) is a well-known probiotic with a long history of safe use. Recent changes in the taxonomy of enterococci have shown that a novel species, Enterococcus lactis, is closely related with E. faecium and occurs together with other enterococci in a phylogenetically well-defined E.

View Article and Find Full Text PDF

Scope: Modifications in intestinal microbiota and its metabolites, the short-chain fatty acids (SCFA) are main factors altering intestinal epithelial barrier integrity and eliciting the onset of a meta-inflammation observed in obesity. The present study is aimed at evaluating the efficacy of Enterococcus faecium (SF68) administration in counteracting the impairment of gut barrier and enteric inflammation in a model of diet-induced obesity, characterizing the molecular mechanisms underlying such beneficial effects.

Methods And Results: Male C57BL/6J mice, fed with standard diet (SD) or high-fat diet (HFD), are treated with SF68 (10  CFU day ).

View Article and Find Full Text PDF
Article Synopsis
  • Scientists are studying probiotics, which are tiny good germs, to help prevent and treat obesity by changing the bacteria in the gut.
  • In an experiment, mice on a high-fat diet were given a specific probiotic called SF68 to see if it could help them gain less weight and improve their gut bacteria.
  • The results showed that mice taking SF68 gained less weight and had better gut bacteria that helped reduce inflammation and sugar levels in their bodies, making it a promising treatment for obesity.
View Article and Find Full Text PDF

A virulence factor as a therapeutic: the probiotic SF68 arginine deiminase inhibits innate immune signaling pathways.

Gut Microbes

August 2022

Department of Veterinary Medicine, Institute of Microbiology and Epizootics, Centre for Infection Medicine, Free University of Berlin, Berlin, Germany.

The probiotic bacterial strain SF68 has been shown to alleviate symptoms of intestinal inflammation in human clinical trials and animal feed supplementation studies. To identify factors involved in immunomodulatory effects on host cells, SF68 and other commensal and clinical isolates were screened using intestinal epithelial cell lines harboring reporter fusions for NF-κB and JNK(AP-1) activation to determine the responses of host cell innate immune signaling pathways when challenged with bacterial protein and cell components. Cell-free, whole-cell lysates of SF68 showed a reversible, inhibitory effect on both NF-κB and JNK(AP-1) signaling pathway activation in intestinal epithelial cells and abrogated the response to bacterial and other Toll-like receptor (TLR) ligands.

View Article and Find Full Text PDF

Norepinephrine and Serotonin Can Modulate the Behavior of the Probiotic NCIMB10415 towards the Host: Is a Putative Surface Sensor Involved?

Microorganisms

February 2022

Laboratory of Microbial Biochemistry and Proteomics, Department of Life Sciences and Systems Biology, University of Turin, Via Accademia Albertina 13, 10123 Torino, Italy.

The human gut microbiota has co-evolved with humans by exchanging bidirectional signals. This study aims at deepening the knowledge of this crucial relationship by analyzing phenotypic and interactive responses of the probiotic NCIMB10415 ( SF68) to the top-down signals norepinephrine (NE) and serotonin (5HT), two neuroactive molecules abundant in the gut. We treated NCIMB10415 with 100 µM NE and 50 µM 5HT and tested its ability to form static biofilm (Confocal Laser Scanning Microscopy), adhere to the Caco-2/TC7 monolayer, affect the epithelial barrier function (Transepithelial Electrical Resistance) and human dendritic cells (DC) maturation, differentiation, and cytokines production.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!